The drug eirenz inhibits?
**Core Concept**
Eirenz, also known as efavirenz, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV/AIDS. It works by selectively binding to the reverse transcriptase enzyme, thereby inhibiting viral replication.
**Why the Correct Answer is Right**
Eirenz specifically binds to the reverse transcriptase enzyme, altering its conformation and preventing the enzyme from initiating DNA synthesis. This action is crucial in the replication cycle of retroviruses like HIV. The binding of eirenz to the reverse transcriptase enzyme occurs at a distinct site, which is separate from the active site where nucleoside analogs bind. This unique binding site allows eirenz to inhibit viral replication without compromising host cell function.
**Why Each Wrong Option is Incorrect**
**Option A:** Eirenz does not inhibit protease enzymes, which are targeted by protease inhibitors like lopinavir and atazanavir.
**Option B:** Eirenz is not a nucleoside reverse transcriptase inhibitor (NRTI), which includes drugs like zidovudine and lamivudine.
**Option C:** Eirenz does not inhibit integrase enzymes, which are targeted by integrase strand transfer inhibitors like raltegravir.
**Clinical Pearl / High-Yield Fact**
Eirenz is known to cause central nervous system (CNS) side effects, including vivid dreams, insomnia, and psychosis. These side effects are thought to be related to its ability to bind to the sigma-1 receptor in the brain.
**Correct Answer: D. Reverse transcriptase.